CN107478853A - A kind of apolipoprotein B detection kit and detection method - Google Patents

A kind of apolipoprotein B detection kit and detection method Download PDF

Info

Publication number
CN107478853A
CN107478853A CN201710678621.9A CN201710678621A CN107478853A CN 107478853 A CN107478853 A CN 107478853A CN 201710678621 A CN201710678621 A CN 201710678621A CN 107478853 A CN107478853 A CN 107478853A
Authority
CN
China
Prior art keywords
reagent
apolipoprotein
preservative
nonidet
buffer solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710678621.9A
Other languages
Chinese (zh)
Other versions
CN107478853B (en
Inventor
耿英利
罗湘宇
甘萍萍
黎明
龙腾镶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mike Biological Ltd By Share Ltd
Original Assignee
Mike Biological Ltd By Share Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mike Biological Ltd By Share Ltd filed Critical Mike Biological Ltd By Share Ltd
Priority to CN201710678621.9A priority Critical patent/CN107478853B/en
Publication of CN107478853A publication Critical patent/CN107478853A/en
Application granted granted Critical
Publication of CN107478853B publication Critical patent/CN107478853B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention provides a kind of apolipoprotein B detection kit, it includes reagent R1 and reagent R2, included in wherein reagent R1 in Nonidet P40 0.9 52g/L, reagent R2 and include the 52g/L of Nonidet P40 0.9, the 16g/L of magnesium salts 0.01, the 20g/L of calcium acetate 0.01 and antibody.Kit antibody performance of the invention is good, reproducible, reagent testing result is accurate, disclosure satisfy that requirement.

Description

A kind of apolipoprotein B detection kit and detection method
Technical field
The present invention relates to medical immunology in-vitro diagnosis field, and in particular to a kind of apolipoprotein B detection kit and detection Method.
Background technology
Turbidimetry is widely used in clinical examination work.It is immunoturbidimetry that application is most common now.
It is all by observing the formation of sediment, aggegation and the generation of haemolysis that the immuno analytical method of early stage is most of The presence or absence of specific protein and content in testing sample are analyzed in the light scattering caused by aggregate with measure, such as immune to expand Scattered, immunoelectrophoresis, direct and brief introduction blood clotting, passive hemagglutination, complement fixation test etc., these detection method costs are low, result is easy In judgement, technically it is easy to grasp, can be widely used for detecting polytype clinical sample.But because above method operation is numerous It is trivial, time-consuming and sensitivity and poor accuracy and tend to be eliminated.
Immunoturbidimetry overcomes disadvantages mentioned above, and quantitatively accurate automation can be developed with reference to the demand of clinic Instrument.Therefore, for immunology detection, immunoturbidimetry has immunology antigen, the specificity of antibody binding, has again Biotrepy feature, during body fluid can be detected in automation biochemical instruments, the micro test substance particularly in blood, It is a kind of clinical examination practical technique having very much using future.
Immunoturbidimetry (Turbidimetric inhibition immuno assay) is that antigen-antibody combines dynamic survey Determine method.Its general principle is:When antigen and antibody react and suitable (the general provision antibody of ratio in special dilution system It is excessive) when, in the presence of the poly- agent of rush of the soluble immune complex of formation in dilution system, separate out, formed micro- from liquid phase Grain, makes reaction solution turbidity occur.When antibody concentration is fixed, the amount of the immune complex of formation is with the increasing of amount of antigen in sample Add and increase, the turbidity of reaction solution is consequently increased.Compareed by the turbidity for determining reaction solution with series of standards product, you can meter Calculate the content of antigen in sample.
The various detecting instruments developed according to the general principle of immunoturbidimetry, developed have been widely used in clinical inspection The many aspects tested, it is the basic functional principle of Blood coagulation instrument optical method and immunization;It is the load fat in full-automatic biochemical measure Albumen, haptens and other protein measuring principles;It can also be applied to microorganism detection simultaneously.By accurately to more Kind material is quantified, and the diagnosis, treatment and prognosis evaluation to many diseases have larger clinical meaning.
The conventional immunoturbidimetry of clinic because its sample dosage is few, can directly on automatic clinical chemistry analyzer batch sample Analyze, be simple to operate, but the reagent and method established at present all have some shortcoming and defect, are mainly manifested in:
Antibody is easy to cotton-shaped or flaky precipitate occur during preservation, cause antibody performance be deteriorated, repeatability it is bad, The coefficient of variation (CV) becomes big, directly contributes reagent testing result inaccuracy, and increases filtration step, complex operation, and filters Antibody may be removed, influences Detection results, patient is affected, it is impossible to meets requirement.
The content of the invention
To solve the above problems, the invention discloses a kind of apolipoprotein B detection kit and detection method, stable reagent Property is good, homogeneity is good, testing result accuracy is good, easy to operate, easy to utilize.
For achieving the above object, the present invention provides following technical scheme:
We's invention provides a kind of apolipoprotein B detection kit, wherein including reagent R1 and reagent R2, the reagent In R1 include Nonidet P40 0.9-52g/L, the reagent R2 in comprising Nonidet P40 0.9-52g/L, Magnesium salts 0.01-16g/L, calcium acetate 0.01-20g/L and antibody 10-1000mg/L.
A kind of apolipoprotein B detection kit, Nonidet P40 is 5-40g/L in the reagent R1, is preferably 28g/L;Nonidet P40 is 4.5-41g/L, preferably 30g/L in the reagent R2.
A kind of apolipoprotein B detection kit, the magnesium salts are 0.05-10g/L, preferably 6g/L;The magnesium salts is preferred For the one or more in magnesium sulfate, magnesium chloride or magnesium acetate.
A kind of apolipoprotein B detection kit, the calcium acetate are 0.05-16g/L, preferably 12g/L.
Wherein,
Buffer solution, inorganic salts, preservative and aggregation are also included in the reagent R1;Preferably, in the reagent R1 also Include buffer solution 20-150mmol/L, inorganic salts 1-30g/L, preservative 0.5-1g/L and aggregation 1-60g/L.
Buffer solution, inorganic salts and preservative are also included in the reagent R2, it is preferable that also comprising buffering in the reagent R2 Liquid 20-100mmol/L, inorganic salts 1-30g/L and preservative 0.5-1g/L.
A kind of apolipoprotein B detection kit, wherein also including calibration object, the calibration object is calibrated using multiple spot, described Calibration object includes buffer solution 20-100mmol/L, inorganic salts 1-30g/L, preservative 0.1-2g/L, glucan 0.3-100g/L, sea Algae sugar 1-100g/L, sucrose 1-100g/L, bovine serum albumin(BSA) 1-100g/L and antigen.
A kind of apolipoprotein B detection kit, wherein comprising including buffer solution in reagent R1 and reagent R2, the reagent R1 The poly- second two of 20-150mmol/L, inorganic salts 1-30g/L, preservative 0.5-1g/L, Macrogol 6000 1-60g/L, ethylphenyl In alcohol 0.9-52g/L, the reagent R2 comprising buffer solution 20-100mmol/L, inorganic salts 1-30g/L, preservative 0.5-1g/L, Antibody 10-1000mg/L, Nonidet P40 0.9-52g/L, magnesium sulfate 0.01-16g/L, calcium acetate 0.01-20g/L;
Preferably,
Buffer solution 20-150mmol/L, inorganic salts 1-30g/L, preservative 0.5-1g/L, poly- second are included in the reagent R1 In the 1-60g/L of glycol 6000, Nonidet P40 5-40g/L, the reagent R2 comprising buffer solution 20-100mmol/L, Inorganic salts 1-30g/L, preservative 0.5-1g/L, antibody 10-1000mg/L, Nonidet P40 4.5-41g/L, magnesium sulfate 0.05-10g/L, calcium acetate 0.05-16g/L;
It is highly preferred that
Buffer solution 20-150mmol/L, inorganic salts 1-30g/L, preservative 0.5-1g/L, poly- second are included in the reagent R1 Buffer solution 20-100mmol/L, nothing are included in the 1-60g/L of glycol 6000, Nonidet P40 28g/L, the reagent R2 Machine salt 1-30g/L, preservative 0.5-1g/L, antibody 10-1000mg/L, Nonidet P40 30g/L, magnesium sulfate 6g/L, Calcium acetate 12g/L.
A kind of apolipoprotein B detection kit,
Preferably, the antibody is goat-anti people, rabbit-anti people, horse is anti-human, mouse is anti-human or other animal anti-human antibodies;
Preferably, the buffer solution be acetate buffer, ammonium chloride buffer, phosphate buffer, TRIS buffer solutions, One or more in borate buffer, glycine buffer, CAPSO, MOPS or Hepes buffer solution;
Preferably, the inorganic salts are one or both of sodium chloride, potassium chloride;
Preferably, the preservative is Sodium azide, phenol, P-hydroxybenzoic acid, ethyl-para-hydroxybenzoate or ethyl mercury One or more in sodium thiosulfate;
Preferably, the aggregation is polyethylene glycol 2000, Macrogol 4000, Macrogol 6000 or polyethylene glycol One or more in 8000;
Present aspect additionally provides a kind of detection method using above-mentioned apolipoprotein B detection kit, comprises the following steps:
(1) add reagent R1 into testing sample to mix, testing sample and reagent R1 are (1-9) by volume:300 add Enter, 37 DEG C of incubations, under certain wavelength, read absorbance A 1;
(2) add reagent R2 into the mixed liquor of step (1) to mix, reagent R2 and reagent R1 is 1 by volume:(1-6) Add, 37 DEG C of incubations, under certain wavelength, read absorbance A 2;
(3) absorbance △ A, △ A=A2-A1 are drawn;
(4) built-in curve matching model fitting standard curve, root are passed through on automatic clinical chemistry analyzer using calibration object Calculate the content of apolipoprotein B in testing sample automatically according to absorbance.
Signified aggregation is the material for promoting antigen-antibody aggegation in the reaction in the present invention.
It is as follows to be related to raw material sources in present invention offer apolipoprotein B detection kit and detection method:
By adopting the above-described technical solution, the beneficial effects of the invention are as follows:
Apolipoprotein B detection kit and detection method provided by the invention, reagent stability is good, and homogeneity is good, antibody It can stablize and preserve, be not in deposited phenomenon, antibody titer is high, performance is good, and does not have filtration step, easy to operate, into This is cheap, and testing result is accurate, reproducible, has wider versatility.
Embodiment
In order that those skilled in the art more fully understand the technical scheme in the application, with reference to embodiment to this hair It is bright to be described further, it is clear that described embodiment is only some embodiments of the present application, rather than whole implementation Example.Based on the embodiment in the application, what those of ordinary skill in the art were obtained under the premise of creative work is not made Every other embodiment, it should all belong to the scope of the application protection.The apolipoprotein B detection kit of embodiment 1
Reagent R1:
Sulfate buffer 20mmol/L
Sodium chloride 1g/L
Sodium azide 0.5g/L
Macrogol 6000 1g/L
Nonidet P40 0.9g/L
Reagent R2:
Sulfate buffer 20mmol/L
Sodium chloride 1g/L
Sodium azide 0.5g/L
Goat-anti human apolipoprotein b antibody 10mg/L
Nonidet P40 0.9g/L
Magnesium sulfate 0.01g/L
Calcium acetate 0.01g/L
Calibration object:
ApoB antigens with standard dilutions (20mmol/L phosphate buffers, 2g/L sodium chloride, 0.1g/L Sodium azides, 0.4g/L glucans, 1g/L trehaloses, 1g/L sucrose, 2g/L bovine serum albumin(BSA)s) dissolving, is detected and is adjusted with commercially available contrast agents It is whole to 120mg/L, packing is stored in -20 DEG C.Using preceding taking-up, and with standard dilutions be diluted to various concentrations ApoB mark Quasi- product (ApoB antigen concentrations:0mg/L、10mg/L、20mg/L、50mg/L、70mg/L).Then removed with 0.65 μm of membrane filtration Bacterium, place 2~8 DEG C of preservations.The apolipoprotein B detection kit of embodiment 2
Reagent R1:
TRIS buffer solutions 60mmol/L
Potassium chloride 6g/L
Phenol 0.7g/L
Macrogol 6000 25g/L
Nonidet P40 52g/L
Reagent R2:
TRIS buffer solutions 60mmol/L
Potassium chloride 6g/L
Phenol 0.7g/L
Goat-anti human apolipoprotein b antibody 50mg/L
Nonidet P40 52g/L
Magnesium sulfate 16g/L
Calcium acetate 20g/L
Calibration object:
ApoB antigens with standard dilutions (40mmol/LTRIS buffer solutions, 10g/L sodium chloride, 0.1g/L Sodium azides, 50g/L glucans, 25g/L trehaloses, 30g/L sucrose, 20g/L bovine serum albumin(BSA)s) dissolving, with the detection of commercially available contrast agents simultaneously Adjust to 100mg/L, packing and be stored in -20 DEG C.Using preceding taking-up, and it is diluted to standard dilutions the ApoB of various concentrations Standard items (ApoB antigen concentrations:0mg/L、10mg/L、30mg/L、50mg/L、70mg/L).Then with 0.65 μm of membrane filtration It is degerming, place 2~8 DEG C of preservations.
The apolipoprotein B detection kit of embodiment 3
Reagent R1:
Acetate buffer 80mmol/L
Potassium chloride 20g/L
Sodium azide 0.8g/L
Macrogol 6000 50g/L
Nonidet P40 5g/L
Reagent R2:
Acetate buffer 80mmol/L
Potassium chloride 20g/L
Sodium azide 0.8g/L
Goat-anti human apolipoprotein b antibody 300mg/L
Nonidet P40 4.5g/L
Magnesium sulfate 0.05g/L
Calcium acetate 0.05g/L
Calibration object:
ApoB antigens with standard dilutions (80mmol/L acetate buffers, 20g/L sodium chloride, 0.8g/L Sodium azides, 70g/L glucans, 60g/L trehaloses, 60g/L sucrose, 70g/L bovine serum albumin(BSA)s) dissolving, with the detection of commercially available contrast agents simultaneously Adjust to 200mg/L, packing and be stored in -20 DEG C.Using preceding taking-up, and it is diluted to standard dilutions the ApoB of various concentrations Standard items (ApoB antigen concentrations:2mg/L、10mg/L、40mg/L、60mg/L、80mg/L).Then with 0.65 μm of membrane filtration It is degerming, place 2~8 DEG C of preservations.
The apolipoprotein B detection kit of embodiment 4
Reagent R1:
MOPS buffer solutions 120mmol/L
Sodium chloride 20g/L
Sodium azide 1g/L
Macrogol 6000 60g/L
Nonidet P40 40g/L
Reagent R2:
MOPS buffer solutions 100mmol/L
Sodium chloride 20g/L
Sodium azide 1g/L
Goat-anti human apolipoprotein b antibody 600mg/L
Nonidet P40 41g/L
Magnesium sulfate 10g/L
Calcium acetate 16g/L
Calibration object:
ApoB antigens with standard dilutions (100mmol/L MOPS buffer solutions, 25g/L sodium chloride, 2g/L Sodium azides, 20g/L glucans, 100g/L trehaloses, 100g/L sucrose, 100g/L bovine serum albumin(BSA)s) dissolving, examined with commercially available contrast agents Survey and adjust to 160mg/L, packing and be stored in -20 DEG C.Various concentrations are diluted to using preceding taking-up, and with standard dilutions ApoB standard items (ApoB antigen concentrations:0mg/L、20mg/L、40mg/L、70mg/L、100mg/L).Then with 0.45 μm of filter Membrane filtration is degerming, places 2~8 DEG C of preservations.
The apolipoprotein B detection kit of embodiment 5
Reagent R1:
MOPS buffer solutions 150mmol/L
Sodium chloride 30g/L
Sodium azide 1g/L
Macrogol 6000 60g/L
Nonidet P40 28g/L
Reagent R2:
MOPS buffer solutions 100mmol/L
Sodium chloride 30g/L
Sodium azide 1g/L
Goat-anti human apolipoprotein b antibody 1000mg/L
Nonidet P40 30g/L
Magnesium sulfate 6g/L
Calcium acetate 12g/L
Calibration object:
ApoB antigens with standard dilutions (100mmol/L MOPS buffer solutions, 30g/L sodium chloride, 1g/L Sodium azides, 90g/L glucans, 100g/L trehaloses, 100g/L sucrose, 100g/L bovine serum albumin(BSA)s) dissolving, examined with commercially available contrast agents Survey and adjust to 120mg/L, packing and be stored in -20 DEG C.Various concentrations are diluted to using preceding taking-up, and with standard dilutions ApoB standard items (ApoB antigen concentrations:0mg/L、20mg/L、50mg/L、80mg/L、100mg/L).Then with 0.65 μm of filter Membrane filtration is degerming, places 2~8 DEG C of preservations.
The apolipoprotein B detection kit of embodiment 6
Reagent R1:
Sulfate buffer 20mmol/L
Sodium chloride 1g/L
Sodium azide 0.5g/L
Macrogol 6000 1g/L
Nonidet P40 0.9g/L
Reagent R2:
Sulfate buffer 20mmol/L
Sodium chloride 1g/L
Sodium azide 0.5g/L
Goat-anti human apolipoprotein b antibody 10mg/L
Nonidet P40 0.9g/L
Magnesium sulfate 0.01g/L
Calibration object:
ApoB antigens with standard dilutions (20mmol/L phosphate buffers, 2g/L sodium chloride, 0.1g/L Sodium azides, 0.4g/L glucans, 1g/L trehaloses, 1g/L sucrose, 2g/L bovine serum albumin(BSA)s) dissolving, is detected and is adjusted with commercially available contrast agents It is whole to 120mg/L, packing is stored in -20 DEG C.Using preceding taking-up, and with standard dilutions be diluted to various concentrations ApoB mark Quasi- product (ApoB antigen concentrations:0mg/L、10mg/L、20mg/L、50mg/L、70mg/L).Then removed with 0.65 μm of membrane filtration Bacterium, place 2~8 DEG C of preservations.
The apolipoprotein B detection kit of embodiment 7
Reagent R1:
Sulfate buffer 20mmol/L
Sodium chloride 1g/L
Sodium azide 0.5g/L
Macrogol 6000 1g/L
Nonidet P40 0.9g/L
Reagent R2:
Sulfate buffer 20mmol/L
Sodium chloride 1g/L
Sodium azide 0.5g/L
Goat-anti human apolipoprotein b antibody 10mg/L
Nonidet P40 0.9g/L
Calcium acetate 0.01g/L
Calibration object:
ApoB antigens with standard dilutions (20mmol/L phosphate buffers, 2g/L sodium chloride, 0.1g/L Sodium azides, 0.4g/L glucans, 1g/L trehaloses, 1g/L sucrose, 2g/L bovine serum albumin(BSA)s) dissolving, is detected and is adjusted with commercially available contrast agents It is whole to 120mg/L, packing is stored in -20 DEG C.Using preceding taking-up, and with standard dilutions be diluted to various concentrations ApoB mark Quasi- product (ApoB antigen concentrations:0mg/L、10mg/L、20mg/L、50mg/L、70mg/L).Then removed with 0.65 μm of membrane filtration Bacterium, place 2~8 DEG C of preservations.
The apolipoprotein B detection kit of embodiment 8
Reagent R1:
Sulfate buffer 20mmol/L
Sodium chloride 1g/L
Sodium azide 0.5g/L
Macrogol 6000 1g/L
Nonidet P40 0.9g/L
Reagent R2:
Sulfate buffer 20mmol/L
Sodium chloride 1g/L
Sodium azide 0.5g/L
Goat-anti human apolipoprotein b antibody 10mg/L
Polysorbas20 0.9g/L
Calibration object:
ApoB antigens with standard dilutions (20mmol/L phosphate buffers, 2g/L sodium chloride, 0.1g/L Sodium azides, 0.4g/L glucans, 1g/L trehaloses, 1g/L sucrose, 2g/L bovine serum albumin(BSA)s) dissolving, is detected and is adjusted with commercially available contrast agents It is whole to 120mg/L, packing is stored in -20 DEG C.Using preceding taking-up, and with standard dilutions be diluted to various concentrations ApoB mark Quasi- product (ApoB antigen concentrations:0mg/L、10mg/L、20mg/L、50mg/L、70mg/L).Then removed with 0.65 μm of membrane filtration Bacterium, place 2~8 DEG C of preservations.
Different embodiment testing results compare, wherein CV values=STDEV (1-7)/average.
1. preparing the sample that a apolipoprotein B concentration is 40mg/L, sample is repeated to detect with the kit of embodiment 1 7 times, testing result is as shown in table 1.
Table 1:2-8 DEG C preserves 1 month, 3 months, 12 months measurement results
From table 1, apolipoprotein B concentration that embodiment 1 measured 1 month, 3 months, 12 months close to actual value, And the coefficient of variation (CV values) measured) 2% is respectively less than, illustrate that the kit of the present invention is reproducible, stable performance, measurement is accurate Really.
2. preparing the sample that a apolipoprotein B concentration is 1mg/L, detection 7 is repeated to sample with the kit of embodiment 2 Secondary, testing result is as shown in table 2.
Table 2:2-8 DEG C preserves 1 month, 3 months, 12 months measurement results
From table 2, apolipoprotein B concentration that embodiment 2 measured 1 month, 3 months, 12 months close to actual value, And the coefficient of variation measured is respectively less than 2%, illustrate that the kit of the present invention is reproducible, stable performance, measurement is accurate.
3. preparing the sample that a apolipoprotein B concentration is 25mg/L, sample is repeated to detect with the kit of embodiment 3 7 times, testing result is as shown in table 3.
Table 3:2-8 DEG C preserves 1 month, 3 months, 12 months measurement results
From table 3, apolipoprotein B concentration that embodiment 3 measured 1 month, 3 months, 12 months close to actual value, And the coefficient of variation measured is respectively less than 1%, illustrate that the kit of the present invention is reproducible, stable performance, measurement is accurate.
4. preparing the sample that a apolipoprotein B concentration is 70mg/L, sample is repeated to detect with the kit of embodiment 4 7 times, testing result is as shown in table 4.
Table 4:2-8 DEG C preserves 1 month, 3 months, 12 months measurement results
From table 4, apolipoprotein B concentration that embodiment 4 measured 1 month, 3 months, 12 months close to actual value, And the coefficient of variation measured is respectively less than 1%, illustrate that the kit of the present invention is reproducible, stable performance, measurement is accurate.
5. preparing the sample that a apolipoprotein B concentration is 25mg/L, sample is repeated to detect with the kit of embodiment 5 7 times, testing result is as shown in table 5.
Table 5:2-8 DEG C preserves 1 month, 3 months, 12 months measurement results
From table 5, embodiment 5 is actual value in the apolipoprotein B concentration that 1 month, 3 months, 12 months measure, and And the coefficient of variation measured is respectively less than 0.05%, illustrate that the kit of the present invention is reproducible, stable performance, measurement is accurate.
6. preparing the sample that a apolipoprotein B concentration is 40mg/L, sample is repeated to detect with the kit of embodiment 6 7 times, testing result is as shown in table 6.
Table 6:2-8 DEG C preserves 1 month, 3 months, 12 months measurement results
From table 6, embodiment 6 deviates actual value in the apolipoprotein B concentration that 1 month, 3 months, 12 months measure, And the coefficient of variation measured is all higher than 4%, illustrate that the kit repeatability is bad, performance is unstable, measurement is inaccurate.
7. preparing the sample that a apolipoprotein B concentration is 40mg/L, sample is repeated to detect with the kit of embodiment 7 7 times, testing result is as shown in table 7.
Table 7:2-8 DEG C preserves 1 month, 3 months, 12 months measurement results
From table 7, embodiment 7 deviates actual value in the apolipoprotein B concentration that 1 month, 3 months, 12 months measure, And the coefficient of variation measured is all higher than 4%, illustrate that the kit repeatability is bad, performance is unstable, measurement is inaccurate.
8. preparing the sample that a apolipoprotein B concentration is 40mg/L, sample is repeated to detect with the kit of embodiment 8 7 times, testing result is as shown in table 8.
Table 8:2-8 DEG C preserves 1 month, 3 months, 12 months measurement results
From table 8, embodiment 8 deviates actual value in the apolipoprotein B concentration that 1 month, 3 months, 12 months measure, And the coefficient of variation measured is all higher than 5%, illustrate that the kit repeatability is bad, performance is unstable, measurement is inaccurate.
It should be understood that the present invention disclosed is not limited only to specific method, scheme and the material of description, because these Equal alterable.It will also be understood that purpose of the terminology used here just for the sake of the specific embodiment scheme of description, rather than It is intended to limit the scope of the present invention, the scope of the present invention is limited solely by appended claim.
Those skilled in the art, which will also be appreciated that or be able to confirm that, uses no more than normal experiment, institute herein The many equivalents for the specific embodiment of the invention stated.These equivalents are also contained in appended claim.

Claims (10)

  1. A kind of 1. apolipoprotein B detection kit, it is characterised in that:The kit includes reagent R1 and reagent R2, the examination Included in agent R1 in Nonidet P40 0.9-52g/L, the reagent R2 and include Nonidet P40 0.9-52g/ L, magnesium salts 0.01-16g/L, calcium acetate 0.01-20g/L and antibody 10-1000mg/L.
  2. 2. apolipoprotein B detection kit according to claim 1, it is characterised in that:Ethylphenyl in the reagent R1 Polyethylene glycol is 5-40g/L, preferably 28g/L;Nonidet P40 is 4.5-41g/L in the reagent R2, is preferably 30g/L。
  3. 3. apolipoprotein B detection kit according to claim 1 or 2, it is characterised in that:The magnesium salts is 0.05- 10g/L, preferably 6g/L;The magnesium salts is preferably the one or more in magnesium sulfate, magnesium chloride or magnesium acetate.
  4. 4. according to the apolipoprotein B detection kit described in claim any one of 1-3, it is characterised in that:The calcium acetate is 0.05-16g/L, preferably 12g/L.
  5. 5. according to the apolipoprotein B detection kit described in claim any one of 1-4, it is characterised in that:In the reagent R1 Also include buffer solution, inorganic salts, preservative and aggregation;Preferably, buffer solution 20-150mmol/ is also included in the reagent R1 L, inorganic salts 1-30g/L, preservative 0.5-1g/L and aggregation 1-60g/L.
  6. 6. according to the apolipoprotein B detection kit described in claim any one of 1-5, it is characterised in that:In the reagent R2 Also include buffer solution, inorganic salts and preservative, it is preferable that also comprising buffer solution 20-100mmol/L, inorganic in the reagent R2 Salt 1-30g/L and preservative 0.5-1g/L.
  7. 7. according to the apolipoprotein B detection kit described in claim any one of 1-6, it is characterised in that:The kit bag Containing calibration object, the calibration object is calibrated using multiple spot, and the calibration object includes buffer solution 20-100mmol/L, inorganic salts 1-30g/ L, preservative 0.1-2g/L, glucan 0.3-100g/L, trehalose 1-100g/L, sucrose 1-100g/L, bovine serum albumin(BSA) 1- 100g/L and antigen.
  8. A kind of 8. apolipoprotein B detection kit, it is characterised in that:The kit includes reagent R1 and reagent R2, the examination Buffer solution 20-150mmol/L, inorganic salts 1-30g/L, preservative 0.5-1g/L, Macrogol 6000 1-60g/ are included in agent R1 L, Nonidet P40 0.9-52g/L;In the reagent R2 comprising buffer solution 20-100mmol/L, inorganic salts 1-30g/L, Preservative 0.5-1g/L, antibody 10-1000mg/L, Nonidet P40 0.9-52g/L, magnesium sulfate 0.01-16g/L, vinegar Sour calcium 0.01-20g/L;
    Preferably,
    Buffer solution 20-150mmol/L, inorganic salts 1-30g/L, preservative 0.5-1g/L, polyethylene glycol are included in the reagent R1 6000 1-60g/L, Nonidet P40 5-40g/L;Comprising buffer solution 20-100mmol/L, inorganic in the reagent R2 Salt 1-30g/L, preservative 0.5-1g/L, antibody 10-1000mg/L, Nonidet P40 4.5-41g/L, magnesium sulfate 0.05-10g/L, calcium acetate 0.05-16g/L;
    It is highly preferred that
    Buffer solution 20-150mmol/L, inorganic salts 1-30g/L, preservative 0.5-1g/L, polyethylene glycol are included in the reagent R1 6000 1-60g/L, Nonidet P40 28g/L;Buffer solution 20-100mmol/L, inorganic salts are included in the reagent R2 1-30g/L, preservative 0.5-1g/L, antibody 10-1000mg/L, Nonidet P40 30g/L, magnesium sulfate 6g/L, acetic acid Calcium 12g/L.
  9. 9. according to the apolipoprotein B detection kit described in claim any one of 1-8, it is characterised in that:
    The antibody is preferably goat-anti people, rabbit-anti people, horse is anti-human, mouse is anti-human or other animal anti-human antibodies;
    The buffer solution is preferably that acetate buffer, ammonium chloride buffer, phosphate buffer, TRIS buffer solutions, boric acid delay One or more in fliud flushing, glycine buffer, CAPSO, MOPS or Hepes buffer solution;
    The inorganic salts are preferably one or both of sodium chloride, potassium chloride;
    The preservative is preferably Sodium azide, phenol, P-hydroxybenzoic acid, ethyl-para-hydroxybenzoate or ethyl mercury thiosulfuric acid One or more in sodium;
    The aggregation is preferably in polyethylene glycol 2000, Macrogol 4000, Macrogol 6000 or PEG 8000 It is one or more of.
  10. 10. a kind of detection method using above-mentioned apolipoprotein B detection kit, comprise the following steps:
    (1) add reagent R1 into testing sample to mix, testing sample and reagent R1 are (1-9) by volume:300 add, and 37 DEG C be incubated, under certain wavelength, read absorbance A 1;
    (2) add reagent R2 into the mixed liquor of step (1) to mix, reagent R2 and reagent R1 is 1 by volume:(1-6) is added, 37 DEG C of incubations, under certain wavelength, read absorbance A 2;
    (3) absorbance △ A, △ A=A2-A1 are drawn;
    (4) use calibration object on automatic clinical chemistry analyzer by built-in curve matching model fitting standard curve, according to suction Luminosity calculates the content of apolipoprotein B in testing sample automatically.
CN201710678621.9A 2017-08-10 2017-08-10 A kind of apolipoprotein B detection kit and detection method Active CN107478853B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710678621.9A CN107478853B (en) 2017-08-10 2017-08-10 A kind of apolipoprotein B detection kit and detection method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710678621.9A CN107478853B (en) 2017-08-10 2017-08-10 A kind of apolipoprotein B detection kit and detection method

Publications (2)

Publication Number Publication Date
CN107478853A true CN107478853A (en) 2017-12-15
CN107478853B CN107478853B (en) 2018-10-12

Family

ID=60600028

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710678621.9A Active CN107478853B (en) 2017-08-10 2017-08-10 A kind of apolipoprotein B detection kit and detection method

Country Status (1)

Country Link
CN (1) CN107478853B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111024963A (en) * 2019-12-27 2020-04-17 桂林英美特生物技术研究所 Liquid-stable anti-freezing immunoturbidimetric apolipoprotein B single reagent
CN111426845A (en) * 2020-04-07 2020-07-17 中拓生物有限公司 Serum apolipoprotein B determination kit and preparation method and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102584958A (en) * 2012-02-08 2012-07-18 北京天坛生物制品股份有限公司 Purification method for 69KD outer membrane protein of pertussis bacillus
CN102628864A (en) * 2011-12-30 2012-08-08 北京九强生物技术股份有限公司 Kit for determining heart-type fatty acid binding protein in serum or urine by latex enhanced turbidimetric immunoassay
EP2516669A2 (en) * 2009-12-21 2012-10-31 Advanced Liquid Logic, Inc. Enzyme assays on a droplet actuator
CN104237522A (en) * 2012-12-03 2014-12-24 武汉生之源生物科技有限公司 Adiponectin content detection kit and preparation method thereof
WO2017002861A1 (en) * 2015-06-30 2017-01-05 シスメックス株式会社 Cell preservative solution, use of same, and method for producing cell preservative solution
CN106771232A (en) * 2016-12-05 2017-05-31 深圳市鸿美诊断技术有限公司 A kind of nano rubber latex enhancing immunoturbidimetry determines the kit of calprotectin

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2516669A2 (en) * 2009-12-21 2012-10-31 Advanced Liquid Logic, Inc. Enzyme assays on a droplet actuator
CN102628864A (en) * 2011-12-30 2012-08-08 北京九强生物技术股份有限公司 Kit for determining heart-type fatty acid binding protein in serum or urine by latex enhanced turbidimetric immunoassay
CN102584958A (en) * 2012-02-08 2012-07-18 北京天坛生物制品股份有限公司 Purification method for 69KD outer membrane protein of pertussis bacillus
CN104237522A (en) * 2012-12-03 2014-12-24 武汉生之源生物科技有限公司 Adiponectin content detection kit and preparation method thereof
WO2017002861A1 (en) * 2015-06-30 2017-01-05 シスメックス株式会社 Cell preservative solution, use of same, and method for producing cell preservative solution
CN106771232A (en) * 2016-12-05 2017-05-31 深圳市鸿美诊断技术有限公司 A kind of nano rubber latex enhancing immunoturbidimetry determines the kit of calprotectin

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
P.A. CHAPMAN ET AL: "Cattle as a possible source of verocytotoxin-producing Escherichia coli 0157 infections in man", 《EPIDEMIOL. INFECT.》 *
庄一义等: "应用单克隆抗体的脂蛋白(a)免疫比浊测定", 《中华医学检验杂志》 *
程之等: "《病理化验诊断指南》", 30 June 1999, 中国纺织出版社 *
陈铁珊等: "免疫比浊法测定载脂蛋白A-I、载脂蛋白A-II和载脂蛋白B", 《中日友好医院学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111024963A (en) * 2019-12-27 2020-04-17 桂林英美特生物技术研究所 Liquid-stable anti-freezing immunoturbidimetric apolipoprotein B single reagent
CN111426845A (en) * 2020-04-07 2020-07-17 中拓生物有限公司 Serum apolipoprotein B determination kit and preparation method and application thereof

Also Published As

Publication number Publication date
CN107478853B (en) 2018-10-12

Similar Documents

Publication Publication Date Title
CN108303544A (en) A kind of whole blood c reactive protein detection kit
CN107462731B (en) A kind of immune globulin A detection reagent box and detection method
CN102636653A (en) Compounded latex particle-enveloped cystatin C detection kit
CN105842458A (en) Procalcitonin detection kit, and method of measuring content of procalcitonin therewith
CN107462729B (en) A kind of Apolipoprotein A1 detection kit and detection method
CN109444427A (en) A kind of kit detecting human parvovirus IgM antibody
CN107907691A (en) A kind of myoglobin assay kit and its application method
CN107942051A (en) A kind of D dimer detection kits and its application method
CN106370860A (en) Kit and test paper strip for serum immunoglobulin E colloidal gold chromatography quantitative detection
CN107478853B (en) A kind of apolipoprotein B detection kit and detection method
CN106324251A (en) Preparation method of small-fragment BMG antibody and beta2-microglobulin detection kit
CN106290907A (en) Serum amyloid A protein quantitative detecting reagent and detection method in whole blood
CN106771152A (en) A kind of kit of quick detection calprotectin
CN107490675B (en) A kind of Immunoturbidimetric kit and detection method
CN107490696A (en) A kind of Retinal-binding protein detection kit and detection method
CN108627652B (en) It is a kind of to detect based on simple grain diameter and simultaneously the kit of RBP ELISA in serum and urine specimen
CN107462730B (en) A kind of Complement C4 detection kit and detection method
CN107490676B (en) A kind of Complement C_3 detection kit and detection method
CN107449919B (en) A kind of C reactive protein detection kit and detection method
CN107478854B (en) A kind of lipoprotein a detection kit and detection method
CN107490697B (en) A kind of kit for testing prealbumin and detection method
CN107478846B (en) A kind of immunoglobulin G detection reagent box and detection method
CN110133270A (en) A kind of enhancing immunosupress is than turbid antibody screening reagent and its making and use method
CN107356764A (en) A kind of apolipoprotein E detection kit and detection method
CN102369441B (en) Immunoassay method and reagent therefor

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant